[WHO News Release] [Yesterday, 11 June 2019,] Emmanuel Macron, President of the French Republic and Dr Tedros Adhanom Ghebreyesus, WHO Director-General met at WHO Headquarters in Geneva. Image Credits: WHO/A. Tardy. Continue reading ->
A new series of briefing documents aimed at helping European Union (EU) policymakers tackle high medicines prices has been released by the non-profit think tank, Medicines Law and Policy. Image Credits: Medicines Law & Policy, Medicines Law & Policy . Continue reading ->
European Union health ministers’ meeting last week in Romania addressed ways to ensure access to medicines and treatment, especially for youth or those with rare diseases. For innovative and expensive medicines, they discussed possibilities “for the time period between the granting of the marketing authorization, the actual placement on the market and the decision to […] Continue reading ->
[CDDEP Press Release] In a new report, CDDEP researchers identify key barriers that prevent access to antibiotics in LMICs and provides potential solutions to address them. Antibiotic resistance is an emerging global public health threat spurred by the overuse and misuse of antibiotics. While “overuse” of antibiotics is widely accepted as a major health challenge, […] Continue reading ->
The European Union last week brought a dispute against Turkey at the World Trade Organisation (WTO) over new Turkish measures that would require pharmaceutical companies to move drug production to the country in order for those drugs to be eligible for reimbursement under the Turkish health system. Image Credits: Pixabay. Continue reading ->
A new report released today by the World Health Organization and the European Centre for Disease Prevention and Control (ECDC) found that while overall tuberculosis (TB) mortality and incidence rates have steadily fallen in the European region over the past decade, the disease should not be “underestimated.” The report warns that these rates are not sufficient to reach global targets for reducing the disease, further noting that while the European region may have only 2.8 percent of the world’s TB burden, it has 23 percent of the world’s burden of multi-drug resistant TB (MDR-TB). Continue reading ->
The Geneva-based International Generic and Biosimilar medicines Association (IGBA) has named industry veteran Suzette Kox as secretary general. Image Credits: International Generic and Biosimilar medicines Association. Continue reading ->
Italian Health Minister Giulia Grillo has proposed that sweeping reforms be considered by the World Health Organization and its member states to increase global transparency of drug prices -- which may be unaffordable to most people in the developing world and increasingly costly for patients and health systems in high-income countries. Continue reading ->
A ground-breaking new high-tech patient safety system to catch falsified medicines in the supply chain in Europe went into effect today, allowing prescription medicines to undergo verification for authenticity before reaching patients. Continue reading ->
Switzerland, considered to be one of the richest countries in the world and home to significant medical research and development, has begun feeling the pressure of high drug prices for its citizens. This has led it to begin talking with other countries exploring joint procurement initiatives aimed at lowering prices, the Swiss global health ambassador told Health Policy Watch in a recent interview. Continue reading ->